# Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis

> **NCT01245140** · PHASE2 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 33 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** alitretinoin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01245140
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04-26
- **Primary completion:** 2014-03-12
- **Final completion:** 2014-04-16
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2017-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01245140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01245140, "Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01245140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*